A Randomized, Embedded, Multifactorial Adaptive Platform trial for ILD (REMAP-ILD): The conceptual design
Tejaswini Kulkarni(University of Alabama at Birmingham), Gísli Jenkins(Imperial College London), Anne E. Holland(Alfred Health), Nazia Chaudhuri(University of Ulster), Christopher J. Ryerson(University of British Columbia), Kerri A. Johannson(University of Calgary), Sally Singh(University of Glasgow), Steven D. Nathan(Inova Fairfax Hospital), María Molina‐Molina(Instituto de Salud Carlos III), Lucilla Piccari(Assistance Publique – Hôpitaux de Paris), Pilar Rivera‐Ortega(Manchester University NHS Foundation Trust), Sydney B. Montesi(Massachusetts General Hospital), Michael Kreuter(Johannes Gutenberg University Mainz), Letícia Kawano-Dourado(Universidade de São Paulo), Wendy Adams, Gary M. Hunninghake(Hubei University of Science and Technology)
Cited by 2
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
|American Journal of Respiratory and Critical Care Medicine|2013|3.8k
American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation
|American Journal of Respiratory and Critical Care Medicine|2006|2k
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2012|1.3k